Melphalan for Use With the Hepatic Delivery System Treatment in Patients With Unresectable Hepatocellular Carcinoma or Intra Hepatic Cholangiocarcinoma

NCT02415036 · clinicaltrials.gov ↗

PHASE2

Phase

TERMINATED

Status

17

Enrollment

INDUSTRY

Sponsor class

Stopped Limited enrollment

Conditions

Hepatocellular Carcinoma
Intrahepatic Cholangiocarcinoma

Interventions

DEVICE: Delcath Hepatic Delivery System
DRUG: Melphalan

Sponsor

Delcath Systems Inc.